Senior Brand Manager |
Shanghai (Shanghai) |
China |
International |
Pharmaceuticals |
Marketing |
29. April 2024 |
Brand Manager |
Shanghai (Shanghai) |
China |
International |
Pharmaceuticals |
Marketing |
29. April 2024 |
Product Manager |
Hong Kong |
Hong Kong Special Administrative Region, China |
International |
Pharmaceuticals |
Marketing |
29. April 2024 |
Associate Director OPX Portfolio Management (CZ, Spain, India) |
Prague |
Tschechische Republik |
Operations |
CTS |
|
29. April 2024 |
Senior Expert Science & Technology - II |
Changshu (Jiangsu Province) |
China |
Development |
Pharmaceuticals |
Research & Development |
29. April 2024 |
Senior Consultant – M&A Post-merger Integrations | Separations |
Prague |
Tschechische Republik |
Operations |
CTS |
BD&L & Strategic Planning |
29. April 2024 |
Senior Consultant |
Prague |
Tschechische Republik |
Operations |
CTS |
BD&L & Strategic Planning |
29. April 2024 |
Maintenance & Calibration Technician (2nd shift) |
Millburn |
USA |
Operations |
Pharmaceuticals |
Technical Operations |
29. April 2024 |
Assoc. Dir. DDIT OPX Planning |
Prague |
Tschechische Republik |
Operations |
CTS |
|
29. April 2024 |
Oncology Specialist - RLT- Portland- Remote |
Field Sales (USA) |
USA |
US |
Pharmaceuticals |
Der Umsatz |
29. April 2024 |
Medical Director/Senior Medical Director-Radiopharmaceuticals (RLT ) |
Remote Position (USA) |
USA |
US |
Pharmaceuticals |
Research & Development |
29. April 2024 |
Director Data Science |
INSURGENTES |
Mexiko |
Operations |
CTS |
Data Science |
29. April 2024 |
AD, Market Access Contracting & Analytics - Remote |
Remote Position (USA) |
USA |
US |
Pharmaceuticals |
Market Access |
29. April 2024 |
Clinical Development Medical Director |
East Hanover |
USA |
Development |
Pharmaceuticals |
Research & Development |
29. April 2024 |
Area Marketing Manager |
Shenyang (Liaoning Province) |
China |
International |
Pharmaceuticals |
Marketing |
29. April 2024 |
(高级)医药代表 /(资深)产品专员 |
Chengdu (Sichuan Province) |
China |
International |
Pharmaceuticals |
Der Umsatz |
29. April 2024 |
Analyst |
Hyderabad (Office) |
Indien |
Operations |
CTS |
Marketing |
29. April 2024 |
Area Marketing Manager |
Beijing (Beijing) |
China |
International |
Pharmaceuticals |
Marketing |
29. April 2024 |
MR |
Beijing (Beijing) |
China |
International |
Pharmaceuticals |
Der Umsatz |
29. April 2024 |
Environmental Social Governance Reporting Lead LACan |
INSURGENTES |
Mexiko |
Finance |
CTS |
Audit und Finanzen |
29. April 2024 |
LDC Commercial Adopt Manager - Revenue Management |
INSURGENTES |
Mexiko |
Operations |
CTS |
Audit und Finanzen |
29. April 2024 |
LDC Commercial Adopt Manager - Order to Cash |
INSURGENTES |
Mexiko |
Operations |
CTS |
Audit und Finanzen |
29. April 2024 |
(高级)医药代表 /(资深)产品专员 |
Chengdu (Sichuan Province) |
China |
International |
Pharmaceuticals |
Der Umsatz |
29. April 2024 |
LDC Commercial Adopt Process Manager - Pricing & Contracting |
INSURGENTES |
Mexiko |
Operations |
CTS |
Audit und Finanzen |
29. April 2024 |
MSL Tumeurs Solides - Nord Est |
Field Non-Sales (France) |
Frankreich |
International |
Pharmaceuticals |
Research & Development |
29. April 2024 |
(高级)医药代表 /(资深)产品专员 |
Chengdu (Sichuan Province) |
China |
International |
Pharmaceuticals |
Der Umsatz |
29. April 2024 |
(高级)医药代表 /(资深)产品专员 |
Chengdu (Sichuan Province) |
China |
International |
Pharmaceuticals |
Der Umsatz |
29. April 2024 |
(高级)医药代表 /(资深)产品专员 |
Chengdu (Sichuan Province) |
China |
International |
Pharmaceuticals |
Der Umsatz |
29. April 2024 |
(高级)医药代表 /(资深)产品专员 |
Chengdu (Sichuan Province) |
China |
International |
Pharmaceuticals |
Der Umsatz |
29. April 2024 |
(高级)医药代表 /(资深)产品专员 |
Chengdu (Sichuan Province) |
China |
International |
Pharmaceuticals |
Der Umsatz |
29. April 2024 |
(高级)医药代表 /(资深)产品专员 |
Chengdu (Sichuan Province) |
China |
International |
Pharmaceuticals |
Der Umsatz |
29. April 2024 |
(高级)医药代表 /(资深)产品专员 |
Chengdu (Sichuan Province) |
China |
International |
Pharmaceuticals |
Der Umsatz |
29. April 2024 |
(高级)医药代表 /(资深)产品专员 |
Shanghai (Shanghai) |
China |
International |
Pharmaceuticals |
Der Umsatz |
29. April 2024 |
(高级)医药代表 /(资深)产品专员 |
Zhengzhou (Henan Province) |
China |
International |
Pharmaceuticals |
Der Umsatz |
29. April 2024 |
(高级)医药代表 /(资深)产品专员 |
Chengdu (Sichuan Province) |
China |
International |
Pharmaceuticals |
Der Umsatz |
29. April 2024 |
(高级)医药代表 /(资深)产品专员 |
Yinchuan (Ningxia Province) |
China |
International |
Pharmaceuticals |
Der Umsatz |
29. April 2024 |
Manager |
Hyderabad (Office) |
Indien |
Operations |
CTS |
Marketing |
28. April 2024 |
Analyst |
Hyderabad (Office) |
Indien |
Operations |
CTS |
Marketing |
28. April 2024 |
Manager |
Hyderabad (Office) |
Indien |
Operations |
CTS |
Marketing |
28. April 2024 |
Analyst |
Hyderabad (Office) |
Indien |
Operations |
CTS |
Marketing |
28. April 2024 |
Brand Manager |
Shanghai (Shanghai) |
China |
International |
Pharmaceuticals |
Marketing |
28. April 2024 |
Brand Manager |
Shanghai (Shanghai) |
China |
International |
Pharmaceuticals |
Marketing |
28. April 2024 |
Principal Scientist - Pathology |
Telangana |
Indien |
Biomedical Research |
Pharma Research |
Research & Development |
28. April 2024 |
Brand Manager |
Shanghai (Shanghai) |
China |
International |
Pharmaceuticals |
Marketing |
28. April 2024 |
县域主任(主管) |
Honghe (Yunnan Province) |
China |
International |
Pharmaceuticals |
Der Umsatz |
28. April 2024 |
Project & site procurement manager |
Changping County (Beijing) |
China |
Operations |
Pharmaceuticals |
Beschaffung |
27. April 2024 |
Medical Advisor (Rheumatology) |
Moscow (City) |
Russische Foed. |
International |
Pharmaceuticals |
Research & Development |
27. April 2024 |
Associate Director, DDIT M&A Deal Enablement Account Management |
Prague |
Tschechische Republik |
Operations |
DATA, DIGITAL & IT |
|
26. April 2024 |
Senior Process Expert (f/m/d) |
Schaftenau |
Österreich |
Operations |
LARGE MOLECULES |
Technical Operations |
26. April 2024 |
Operational Excellence Expert (m/f/d) |
Schaftenau |
Österreich |
Operations |
LARGE MOLECULES |
Technical Operations |
26. April 2024 |